Total Payments
$2,260
2024 Payments
$68.29
Companies
19
Transactions
178
Medicare Patients
15,766
Medicare Billing
$2.5M
Payment Breakdown by Category
Food & Beverage$2,260 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,260 | 178 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $578.99 | 68 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $321.03 | 29 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $269.64 | 11 | $0 (2022) |
| GlaxoSmithKline, LLC. | $259.69 | 14 | $0 (2023) |
| ABBVIE INC. | $239.96 | 16 | $0 (2024) |
| Allergan Inc. | $217.07 | 18 | $0 (2017) |
| IRONWOOD PHARMACEUTICALS, INC | $96.02 | 4 | $0 (2024) |
| Novo Nordisk Inc | $53.82 | 4 | $0 (2022) |
| Merck Sharp & Dohme LLC | $47.09 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $34.43 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68.29 | 3 | IRONWOOD PHARMACEUTICALS, INC ($26.28) |
| 2023 | $154.04 | 9 | GlaxoSmithKline, LLC. ($85.92) |
| 2022 | $616.41 | 49 | Janssen Pharmaceuticals, Inc ($239.40) |
| 2021 | $662.95 | 69 | Janssen Pharmaceuticals, Inc ($327.57) |
| 2020 | $196.47 | 6 | AstraZeneca Pharmaceuticals LP ($139.39) |
| 2019 | $101.80 | 6 | AstraZeneca Pharmaceuticals LP ($43.46) |
| 2018 | $136.74 | 10 | AbbVie, Inc. ($51.44) |
| 2017 | $323.48 | 26 | Allergan Inc. ($217.07) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $26.28 | General |
| Category: GI | ||||||
| 12/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $29.59 | General |
| Category: GI | ||||||
| 07/17/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/05/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: UROLOGY | ||||||
| 12/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $12.11 | General |
| Category: Cardiovascular | ||||||
| 11/29/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $9.47 | General |
| Category: Cardiovascular | ||||||
| 10/03/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $9.47 | General |
| Category: Cardiovascular | ||||||
| 09/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: DIABETES | ||||||
| 09/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Diabetes | ||||||
| 09/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $9.47 | General |
| Category: Cardiovascular | ||||||
| 08/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,898 | 10,940 | $1.3M | $656,395 |
| 2022 | 20 | 3,841 | 10,304 | $1.3M | $638,736 |
| 2021 | 21 | 4,152 | 10,904 | $1.3M | $650,743 |
| 2020 | 20 | 3,875 | 10,398 | $1.2M | $590,098 |
Total Patients
15,766
Total Services
42,546
Medicare Billing
$2.5M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 458 | 2,077 | $373,860 | $185,731 | 49.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 265 | 2,728 | $245,520 | $145,980 | 59.5% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 88 | 1,126 | $168,900 | $65,610 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 343 | 890 | $124,600 | $60,715 | 48.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 97 | 1,144 | $171,600 | $47,799 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 297 | 297 | $44,550 | $41,687 | 93.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 332 | 336 | $36,960 | $27,945 | 75.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 140 | 367 | $29,360 | $15,627 | 53.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 69 | 69 | $10,350 | $9,025 | 87.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 317 | 317 | $28,530 | $8,749 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 231 | 234 | $9,360 | $7,820 | 83.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 89 | 89 | $7,120 | $6,747 | 94.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 317 | 317 | $12,680 | $6,549 | 51.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 309 | 309 | $12,360 | $6,384 | 51.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 50 | 97 | $8,730 | $4,508 | 51.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $9,020 | $2,920 | 32.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 63 | $5,580 | $2,713 | 48.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 139 | 140 | $5,600 | $2,478 | 44.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 77 | 77 | $3,850 | $2,437 | 63.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 72 | 72 | $2,480 | $2,181 | 87.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 69 | 69 | $3,450 | $1,412 | 40.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,160 | $774.40 | 35.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 35 | 36 | $900.00 | $302.40 | 33.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 17 | 20 | $500.00 | $188.18 | 37.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $650.00 | $113.94 | 17.5% |
About Dr. Dejun Wang, M.D
Dr. Dejun Wang, M.D is a Internal Medicine healthcare provider based in Rowland Heights, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275559288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dejun Wang, M.D has received a total of $2,260 in payments from pharmaceutical and medical device companies, with $68.29 received in 2024. These payments were reported across 178 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,260).
As a Medicare-enrolled provider, Wang has provided services to 15,766 Medicare beneficiaries, totaling 42,546 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Rowland Heights, CA
- Active Since 07/14/2006
- Last Updated 11/06/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275559288
Products in Payments
- XARELTO (Drug) $397.12
- Livalo (Drug) $291.91
- FARXIGA (Drug) $269.64
- INVOKANA (Drug) $181.87
- LINZESS (Drug) $160.45
- TRELEGY ELLIPTA (Drug) $142.46
- Creon (Drug) $103.05
- Linzess (Drug) $96.02
- NAMZARIC (Drug) $84.53
- VRAYLAR (Drug) $75.21
- AREXVY (Drug) $50.76
- VERQUVO (Drug) $47.09
- ANORO (Drug) $38.70
- XIFAXAN (Drug) $34.43
- Ozempic (Drug) $29.43
- SEGLENTIS (Drug) $29.12
- ANORO ELLIPTA (Drug) $27.77
- Rybelsus (Drug) $24.39
- NEXLETOL (Drug) $18.45
- VIBERZI (Drug) $17.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rowland Heights
Dr. Jason Paek, M.d, M.D
Internal Medicine — Payments: $20,778
Internal Medicine $20,778
Xipu Wu, Md, MD
Internal Medicine — Payments: $19,079
Internal Medicine $19,079
Mary Wang, Md, MD
Internal Medicine — Payments: $17,887
Internal Medicine $17,887
Zune Liu, Md, MD
Internal Medicine — Payments: $16,038
Internal Medicine $16,038
Yongqing Feng, M.d, M.D
Internal Medicine — Payments: $1,249
Internal Medicine $1,249
Kuo Hsien Chang, Md, MD
Internal Medicine — Payments: $71.89
Internal Medicine $71.89